Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease.

被引：0
|
作者：
Raut, Nirmal Vivek
Bharde, Atul
Gourishankar, Aland
Jayant, Sreeja
Garbhe, Meghana
Gosavi, Sayali
Janorkar, Apoorva
D'Souza, Alain
Vasudevan, Aravindan
Khandare, Jayant
机构：
[1] Dr Vishwanath Karad World Peace Univ, Sch Consciousness, Pune, India
[2] Savitribai Phule Pune Univ, Pune, India
[3] Actorius Innovat & Res Pvt Ltd, Pune, India
[4] Actorius Res & Innovat, Pune, India
[5] Actorius Res & Innovat Co, Cupertino, CA USA
[6] Onecell Diag, Cupertino, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15021
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CIRCULATING TUMOR CELLS IN MEDULLOBLASTOMA: A NOVEL PERIPHERAL BIOMARKER FOR CNS DISEASE
    Ozkaya, Tevhide
    Chien, Franklin
    Boya, Mert
    Gray, Rachel
    Arthur, Robert
    Claussen, Henry
    Vega, Jose Velazquez-Vega Velazquez
    Schneiderjan, Matthew
    Bhasin, Manoj
    Sarioglu, Fatih
    Macdonald, Tobey
    NEURO-ONCOLOGY, 2024, 26
  • [42] Cytogenetics and in situ hybridization (FISH) in minimal residual disease.
    Acevedo, S
    MEDICINA-BUENOS AIRES, 2000, 60 : 87 - 90
  • [43] Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
    Tachtsidis, A.
    McInnes, L. M.
    Jacobsen, N.
    Thompson, E. W.
    Saunders, C. M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (06) : 521 - 550
  • [44] Immunomagnetic enrichment of circulating canter cells to improve minimal residual disease detection
    Borgnes, A
    Neurauter, A
    Kullmann, A
    Lycke, K
    Bosnes, M
    Larsen, F
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 620 - 620
  • [45] BIOLOGICAL RESPONSE TO MINIMAL RESIDUAL DISEASE
    REIZENSTEIN, P
    OGIER, C
    HAST, R
    STENKE, L
    LEUKEMIA RESEARCH, 1986, 10 (01) : 108 - 108
  • [46] ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma-Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring
    Choi, Woo Jin
    Ivanics, Tommy
    Gravely, Annabel
    Gallinger, Steven
    Sapisochin, Gonzalo
    O'Kane, Grainne M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3866 - 3867
  • [47] Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
    A. Tachtsidis
    L. M. McInnes
    N. Jacobsen
    E. W. Thompson
    C. M. Saunders
    Clinical & Experimental Metastasis, 2016, 33 : 521 - 550
  • [48] Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer
    Chakrabarti, Sakti
    Mahipal, Amit
    PHARMACOGENOMICS, 2023,
  • [49] The Role of Circulating Tumor DNA in Evaluating Minimal Residual Disease in Luminal Gastrointestinal Malignancies
    Ueberroth, Benjamin E.
    Jones, Jeremy C.
    Bekaii-Saab, Tanios
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 444 - +
  • [50] Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
    Moding, Everett J.
    Nabet, Barzin Y.
    Alizadeh, Ash A.
    Diehn, Maximilian
    CANCER DISCOVERY, 2021, 11 (12) : 2968 - 2986
12345